Emilie C. Bright - Concepedia

Author

Emilie C. Bright

Johns Hopkins University

Also Known As

E Bright, E C Bright, E C. Bright, E. Bright, E.C. Bright, EMILIE C. BRIGHT, Emilie C Bright, Emilie C. Bright

Publications

735

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center

About

Emilie C. Bright is an author at Johns Hopkins University specializing in autoimmunity, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	158
2	Immunology	6	6	158
3	Allergy	3	3	93
4	Cell Biology	2	2	81
5	Marrow Transplantation	1	1	20

Emilie C. Bright

Publications

681

Citations

H-Index

Page 1

	Year	Citations
Association of Foxp3 regulatory gene expression with graft-versus-host disease Yuji Miura, Christopher J. Thoburn, Emilie C. Bright, Blood	2004	312
Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide Allan D. Hess, Emilie C. Bright, Christopher J. Thoburn, Blood	1997	76
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon γ may be critical mediators for the development of autologous GVHD Yuji Miura, Christopher J. Thoburn, Emilie C. Bright, Blood	2002	71
Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression. Anne Fischer, Peter P. Ruvolo, Richard K. Burt, The Journal of Immunology Mediate SgvhdAdaptive Immune SystemT-regulatory CellCellular ImmunologyImmunology	1995	45
Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease. Allan D. Hess, Anne Fischer, L Horwitz, The Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmune SystemImmunotherapy	1994	36
Chemokine Receptor Expression by Leukemic T Cells of Cutaneous T-Cell Lymphoma: Clinical and Histopathological Correlations Elisabetta Capriotti, Eric C. Vonderheid, Christopher J. Thoburn, Journal of Investigative Dermatology Cutaneous T-cell LymphomaLymphoid NeoplasiaChemokine Receptor ExpressionT-regulatory CellImmunology	2007	30
Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD Yuji Miura, Christopher J. Thoburn, Emilie C. Bright, Blood	2001	27
Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells Elsken van der Wall, Thomas Horn, Emilie C. Bright, British Journal of Cancer	2000	21
6: Post-transplantation high-dose cyclophosphamide (Cy) is effective single agent GVHD prophylaxis that permits prompt immune reconstitution after myeloablative HLA matched related and unrelated bone marrow transplantation (BMT) Leo Luznik, Ephraim J. Fuchs, A.R. Chen, Biology of Blood and Marrow Transplantation Post-transplantation High-dose CyclophosphamideTransplantationMarrow TransplantationMyeloablative HlaBone Marrow Failure	2007	20
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand Yuji Miura, Christopher J. Thoburn, Emilie C. Bright, Biology of Blood and Marrow Transplantation	2004	16

Page 1